Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy and Safety of 5-HT4 Receptor Agonist Minesapride for Irritable Bowel Syndrome with Constipation in a Randomized Controlled Trial
Shin Fukudo, Masatoshi Nakamura, Tatsuto Hamatani, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 538-546.e8
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

British Society of Gastroenterology guidelines on the management of irritable bowel syndrome
Dipesh H. Vasant, Peter Paine, Christopher J. Black, et al.
Gut (2021) Vol. 70, Iss. 7, pp. 1214-1240
Open Access | Times Cited: 348
Gut Microbiota Modulates Neurotransmitter and Gut-Brain Signaling
Shiyan Qu, Zijin Yu, Yaxuan Zhou, et al.
Microbiological Research (2024) Vol. 287, pp. 127858-127858
Closed Access | Times Cited: 26
Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
Z. A. Mamieva, Elena Poluektova, В. М. Свистушкин, et al.
World Journal of Gastroenterology (2022) Vol. 28, Iss. 12, pp. 1204-1219
Open Access | Times Cited: 48
The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis
Michelle Bosman, Sigrid Elsenbruch, Maura Corsetti, et al.
˜The œLancet. Gastroenterology & hepatology (2021) Vol. 6, Iss. 6, pp. 459-473
Open Access | Times Cited: 49
Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review
Agnieszka Chlebicz-Wójcik, Katarzyna Śliżewska
Biomolecules (2021) Vol. 11, Iss. 8, pp. 1154-1154
Open Access | Times Cited: 36
Nanocrystalline Cellulose Cures Constipation via Gut Microbiota Metabolism
Mingzheng Wang, Ruitao Cha, Wenshuai Hao, et al.
ACS Nano (2022) Vol. 16, Iss. 10, pp. 16481-16496
Closed Access | Times Cited: 24
Evidence-based clinical guidelines for chronic constipation 2023
Eikichi Ihara, Noriaki Manabe, Hidenori Ohkubo, et al.
Digestion (2024), pp. 1-28
Open Access | Times Cited: 5
Review article: current and future treatment approaches for pain in IBS
Peter Paine
Alimentary Pharmacology & Therapeutics (2021) Vol. 54, Iss. S1
Open Access | Times Cited: 28
Randomised clinical trial: efficacy and safety of the live biotherapeutic product MRx1234 in patients with irritable bowel syndrome
Eamonn M.M. Quigley, Louise Markinson, Alex Stevenson, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 57, Iss. 1, pp. 81-93
Closed Access | Times Cited: 20
Massa Medicata Fermentata treated spleen deficiency constipation by mediating intestinal microbiota and serum peptide
Kangxiao Guo, Yuan Tang, Tao Yang, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Multi-omics technology reveals the changes in gut microbiota to stimulate aromatic amino acid metabolism in children with allergic rhinitis and constipation
Chunyan Wang, Haiying Liu, Xiaoli Li, et al.
Frontiers in Allergy (2025) Vol. 6
Open Access
Protective effect of L-pipecolic acid on constipation in C57BL/6 mice based on gut microbiome and serum metabolomic
Huan Li, Hong-yun Xiao, Liping Yuan, et al.
BMC Microbiology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 8
5-Hydroxytryptamine 4 Receptor Agonist Attenuates Diabetic Enteric Neuropathy through Inhibition of the Receptor-Interacting Protein Kinase 3 Pathway
Yingying Cheng, Yueting Kou, Juan Wang, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 5, pp. 785-795
Open Access | Times Cited: 2
Randomised clinical trial: minesapride vs placebo for irritable bowel syndrome with predominant constipation
Tatsuto Hamatani, Shin Fukudo, Yosuke Nakada, et al.
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 3, pp. 430-441
Open Access | Times Cited: 15
Recent advances in diagnosis and management of irritable bowel syndrome
Karen Van den Houte, Esther Colomier, Jolien Schol, et al.
Current Opinion in Psychiatry (2020) Vol. 33, Iss. 5, pp. 460-466
Closed Access | Times Cited: 13
Diagnostic classification systems for disorders of gut‐brain interaction should include psychological symptoms
Michael Jones, Gerald Holtmann, Jan Tack, et al.
Neurogastroenterology & Motility (2024) Vol. 36, Iss. 12
Open Access | Times Cited: 1
Hybrid Cognitive Behavioral Therapy With Interoceptive Exposure for Irritable Bowel Syndrome: A Feasibility Study
Misako Funaba, Hitomi Kawanishi, Yasushi Fujii, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 9
Protective actions of a luminally acting 5‐HT4 receptor agonist in mouse models of colitis
Molly Hurd, Melody M. Haag, Matthew J. Kwasnik, et al.
Neurogastroenterology & Motility (2023) Vol. 35, Iss. 11
Open Access | Times Cited: 2
Future Direction of Research and Treatment Possibility for Irritable Bowel Syndrome
Shin Fukudo, Yuhei Yamaguchi, Yuka Endo, et al.
(2024), pp. 191-208
Closed Access
5-HT4R Modulators: A Patent Landscape
Patrick Dallemagne, Christophe Rochais
Pharmaceutical Patent Analyst (2021) Vol. 10, Iss. 4, pp. 179-181
Closed Access | Times Cited: 3
Emerging therapies in the management of Irritable Bowel Syndrome (IBS)
Jill E. Elwing, Hadi Atassi, Benjamin D. Rogers, et al.
Expert Opinion on Emerging Drugs (2022) Vol. 27, Iss. 1, pp. 55-73
Closed Access | Times Cited: 2
Editorial: minesapride for irritable bowel syndrome with constipation
Christopher J. Black, Brigida Barberio, Alexander C. Ford
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 4, pp. 713-714
Closed Access | Times Cited: 2
Letter: placebo run‐in for IBS clinical trials—is it useful?
Michelle Bosman, Dániel Keszthelyi
Alimentary Pharmacology & Therapeutics (2020) Vol. 52, Iss. 7, pp. 1237-1238
Open Access | Times Cited: 1
Effect of Liushenqu on intestinal flora distribution and brain-gut petide levels in mice with functional constipation
Kangxiao Guo, Xin Yi, Yuan Tang, et al.
Research Square (Research Square) (2023)
Open Access
Nocebo effects and influencing factors in the randomized clinical trials of chronic constipation: A systematic review and meta‐analysis
H. J. Yang, Jinlu Guo, Xin Yang, et al.
Neurogastroenterology & Motility (2023) Vol. 36, Iss. 2
Closed Access
Page 1 - Next Page

Scroll to top